Reference | Outcome | ns-NSAIDs | Celecoxib | Naproxen | Diclofenac | Ibuprofen | Indomethacin | Meloxica | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Observational studies | Â | n* | aOR | 95%CI | n* | aOR | 95%CI | n* | aOR | 95%CI | n* | aOR | 95%CI | n* | aOR | 95%CI | n* | aOR | 95%CI | n* | aOR | 95%CI |
Case-Crossover | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Present study | AMI | 3573 | 1.42 | 1.3, 1.6 | 210 | 1.36 | 1.0, 2.0 | 231 | 1.26 | 0.9, 1.8 | 1731 | 1.29 | 1.1, 1.5 | 755 | 1.45 | 1.2, 1.8 | 184 | 1.22 | 0.8, 1.8 | 327 | 0.97 | 0.7, 1.3 |
Gislason 2009 [17] | MI in HF | - | 1.56 | 1.2, 2.1 | - | 1.31 | 0.9, 2.0 | - | 1.31 | 0.6, 2.7 | - | 1.64 | 1.2, 2.3 | - | 1.47 | 1.2, 1.9 | - | Â | Â | - | Â | Â |
Gislason 2006 [18] | re MI | 14 | 1.07 | 0.8, 1.5 | 42 | 1.36 | 0.7, 2.5 | - | Â | Â | 61 | 1.67 | 1.2, 2.4 | 136 | 1.32 | 0.7, 2.5 | - | Â | Â | - | Â | Â |
Case-Control | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Garcia Rodriguez 2000 [44] | MI | 167 | 1.45 | 1.2, 1.8 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
Schlienger 2002 [43] | AMI | 242 | 1.17 | 1.0, 1.4 | - | Â | Â | 19 | 0.68 | 0.4, 1.1 | 97 | 1.38 | 1.1, 1.8 | 60 | 1.17 | 0.9, 1.6 | 15 | 1.03 | 0.6, 1.9 | - | Â | Â |
Solomon 2002 [42] | AMI | 390 | 0.86 | 0.6, 1.2 | - | Â | Â | 243 | 0.84 | 0.7, 1.0 | - | Â | Â | 285 | 1.02 | 0.9, 1.2 | - | Â | Â | - | Â | Â |
Watson 2002 [41] | TCEs | - | 1.16 | 0.9, 1.5 | - | Â | Â | 26 | 0.61 | 0.4, 0.9 | - | 1.68 | 1.3, 2.3 | - | 1.05 | 0.6, 1.7 | - | Â | Â | - | Â | Â |
 | MI | - | 1.47 | 1.0, 2.2 | - |  |  | - | 0.57 | 0.3, 1.1 | - | 1.68 | 1.1, 2.5 | - | 0.74 | 0.4, 1.6 | - |  |  | - |  |  |
Garcia Rodriguez 2004 [40] | AMI | 580 | 1.07 | 1.0, 1.2 | - | Â | Â | 49 | 0.89 | 0.6, 1.2 | 213 | 1.18 | 1.0, 1.4 | 155 | 1.06 | 0.9, 1.3 | 29 | 0.86 | 0.6, 1.3 | 25 | 0.97 | 0.6, 1.6 |
Kimmel 2004 [27] | AMI (no aspirin) | 126 | 0.53 | 0.4, 0.7 | - | Â | Â | - | 0.48 | 0.3, 0.8 | - | Â | Â | - | 0.52 | 0.4, 0.7 | - | Â | Â | - | Â | Â |
 | (use aspirin) | 74 | 0.83 | 0.6, 1.2 | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  |
Solomon 2004 [39] | AMI | 371 | 0.98 | - | 425 | 0.93 | 0.8, 1.0 | 63 | 0.98 | - | - | Â | Â | 49 | 0.95 | - | - | Â | Â | - | Â | Â |
Fischer 2005 [28] | AMI | 650 | 1.07 | 1.0, 1.2 | - | Â | Â | 63 | 0.96 | 0.7, 1.4 | 260 | 1.23 | 1.0, 1.5 | 176 | 1.16 | 0.9, 1.5 | 36 | 1.36 | 0.8, 2.3 | - | Â | Â |
Graham 2005 [38] | AMI, CD | 534 | 1.13 | 1.0, 1.3 | 126 | 0.84 | 0.7, 1.0 | 367 | 1·14 | 1.0, 1.3 | - |  |  | 670 | 1·06 | 1.0, 1.2 | - |  |  | - |  |  |
Hippisley-Cox 2005 [37] | AMI | 181 | 1.21 | 1.0, 1.4 | 93 | 1.21 | 1.0, 1.5 | 96 | 1.27 | 1.0, 1.6 | 542 | 1.55 | 1.4, 1.7 | 460 | 1.24 | 1.1, 1.4 | - | Â | Â | - | Â | Â |
Johnsen 2005 [36] | AMI | 532 | 1.68 | 1.5, 1.9 | 71 | 1.25 | 1.0, 1.6 | 26 | 1.50 | 1.0, 2.3 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
Kimmel 2005 [29] | MI | 319 | 0.61 | 0.5, 0.7 | 18 | 0.43 | 0.2, 0.8 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
Levesque 2005 [35] | AMI | 51 | 1.00 | 0.7, 1.4 | 287 | 0.99 | 0.9, 1.2 | 23 | 1.17 | 0.8, 1.8 | - | Â | Â | - | Â | Â | - | Â | Â | 7 | 1.06 | 0.5, 2.3 |
Andersohn 2006 [34] | AMI | 354 | 1.14 | 1.0, 1.2 | 111 | 1.56 | 1.2, 2.0 | 59 | 1.15 | 0.8, 1.6 | 393 | 1.37 | 1.2, 1.6 | 201 | 1.04 | 0.9, 1.3 | - | Â | Â | - | Â | Â |
Hawkey 2006 [33] | MI (cc) | 36 | 1.77 | 1.0, 3.0 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
 | (hc) | 36 | 2.61 | 1.4, 5.0 | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  | - |  |  |
Helin-Salmivaara 2006 [32] | MI | 1985 | 1.34 | 1.3, 1.4 | 124 | 1.06 | 0.8, 1.3 | 300 | 1.19 | 1.0, 1.4 | 388 | 1.35 | 1.2, 1.5 | 768 | 1.41 | 1.3, 1.6 | 108 | 1.56 | 1.2, 2.0 | 149 | 1.06 | 1.0, 1.6 |
Jick 2006 [45] | AMI | - | Â | Â | 62 | 1.40 | 0.9, 2.1 | 44 | 1.40 | 0.8, 2.3 | 94 | 1.00 | 0.8, 1.4 | 102 | 1.2 | 0.9, 1.6 | - | Â | Â | - | Â | Â |
Brophy 2007 [46] | AMI | 51 | 1.01 | 0.7, 1.4 | 287 | 1.03 | 0.9, 1.2 | 23 | 1.18 | 0.8, 1.8 | - | Â | Â | - | Â | Â | - | Â | Â | 7 | 0.88 | 0.4, 1.9 |
Garcia Rodriguez 2008 [31] | MI | 940 | 1.34 | 1.2,1.5 | 81 | 1.33 | 1.0, 1.8 | 54 | 1.04 | 0.7, 1. 5 | 353 | 1.67 | 1.4, 1.9 | 143 | 1.06 | 0.9, 1.3 | 29 | 1.47 | 0.9, 2.4 | 59 | 1.30 | 0.9, 1.8 |
van der Linden 2009 [47] | AMI | 269 | 1.41 | 1.2, 1.6 | 18 | 2.53 | 1.5, 4.2 | - | 1.21 | 0.9, 1.7 | 108 | 1.51 | 1.2, 1.9 | 68 | 1.56 | 1.2, 2.1 | - | Â | Â | - | Â | Â |
Mangoni 2010 [30] | AMI+ | 1803 | 1.02 | 1.0, 1.1 | - | Â | Â | 284 | 0.93~1.31+ | 608 | 0.82~1.04+ | 274 | 0.92~1.32+ | - | Â | Â | 679 | 0.81~1.21+ | Â | Â | Â | Â |
Cohort | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Ray 2002 [26] | AMI, CD | - | Â | Â | 74 | 0.96 | 0.8, 1.2 | 245 | 0.93 | 0.8, 1.1 | - | Â | Â | 190 | 0.91 | 0.8, 1.1 | - | Â | Â | - | Â | Â |
Ray 2002 [25] | AMI, CD | 841 | 1.05 | 1.0, 1.1 | - | Â | Â | 201 | 0.95 | 0.8, 1.1 | - | Â | Â | 339 | 1.15 | 1.0, 1.3 | - | Â | Â | - | Â | Â |
Mamdani 2003 [24] | AMI | 134 | 1.20 | 0.9, 1.4 | 75 | 0.90 | 0.7, 1.2 | 15 | 1.00 | 0.6, 1.7 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
Chan 2006 [23] | CV | 288 | 1.44 | 1.3, 1.7 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
Gislason 2006 [18] | re MI | 14 | 1.27 | 1.1, 1.5 | 42 | 1.50 | 1.1, 2.1 | - | Â | Â | 61 | 1.54 | 1.2, 1.9 | 136 | 1.25 | 1.1, 1.5 | - | Â | Â | - | Â | Â |
Solomon 2006 [22] | AMI, stroke | 292 | 0.95 | 0.8, 1.1 | 1342 | 0.99 | 0.9, 1.1 | 108 | 0.75 | 0.6, 0.9 | 86 | 1.1 | 0.9, 1.4 | 151 | 0.96 | 0.8, 1.1 | - | Â | Â | - | Â | Â |
Hammad 2008 [21] | AMI | 18 | 1.33 | 0.8, 2.2 | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â | - | Â | Â |
van Staa 2008 [20] | AMI | 5690 | 1.12 | 1.1, 1.2 | - | Â | Â | 526 | 1.03 | 0.9, 1.1 | 2033 | 1.21 | 1.2, 1.3 | 1913 | 1.04 | 1.0, 1.1 | 309 | 1.27 | 1.1, 1.4 | 137 | 1.12 | 0.9, 1.3 |
Roumie 2009 [19] | CV (no CV history) | - | Â | Â | 300 | 1.00 | 0.9, 1.1 | 424 | 1.00 | 0.9, 1.1 | 57 | 1.02 | 0.8, 1.3 | 355 | 1.03 | 0.9, 1.2 | 95 | 1.36 | 1.1, 1.7 | - | Â | Â |
 | CV (CV history) | - |  |  | 312 | 0.92 | 0.8, 1.0 | 306 | 0.88 | 0.8, 1.0 | 49 | 1.01 | 0.8, 1.3 | 281 | 1.02 | 0.9, 1.2 | 60 | 0.97 | 0.8, 1.3 | - |  |  |
Gislason 2009 [17] | MI in HF | - | 1.32 | 1.1, 1.5 | - | 1.38 | 1.1, 1.7 | - | 1.52 | 1.1, 2.1 | - | 1.36 | 1.1, 1.6 | - | 1.33 | 1.2, 1.5 | - | Â | Â | - | Â | Â |